Nevia Bio is an innovative health technology company committed to transforming women's health through the discovery of biomarkers in vaginal fluid.

Our mission is to develop non-invasive, AI-driven diagnostic solutions for early detection of gynecological cancers, with an initial focus on ovarian cancer.

By leveraging the world’s largest database of vaginal fluid and multi-omics data, Nevia Bio is pioneering a breakthrough diagnostic platform that has the potential to detect cancers at their earliest and most treatable stages, ultimately improving patient outcomes and reducing treatment costs.